# Noninvasive vs. Invasive Lung Evaluation

> **NCT03615443** · — · COMPLETED · sponsor: **Guardant Health, Inc.** · enrollment: 306 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Guardant360

## Key facts

- **NCT ID:** NCT03615443
- **Lead sponsor:** Guardant Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-12
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615443, "Noninvasive vs. Invasive Lung Evaluation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03615443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*